U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 2,209 records

Showing results for "drug".

  1. Multidisciplinary Postacute Rehabilitation for Moderate to Severe Traumatic Brain Injury in AdultsBrain Injury in Adults Surveillance Report 08082016 CCKK CC final clean (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/traumatic-brain-injury-rehabilitation-surveillance-160902.pdf
    September 02, 2016 - situations"where"a"limited"search"would"produce"prima"facie"evidence"that"a"conclusion" was"out"of"date,"such"as"the"withdrawal"of"a"drug"or"surgical"device"from"the"market … identified"that"clearly"renders"conclusions"from"the"original"systematic"review"out"of"date," such"as"the"addition"or"removal"of"a"drug"or"device"from"the"market"or"a"new"FDA"boxed

  2. Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias: Future Research Needs (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/plasma-cell-dyscrasias-sflc-assay-future_research.pdf
    September 01, 2012 - Food and Drug Administration. … Food and Drug Administration and is classified as an immunoglobulin light chain–specific immunological … • Appropriateness: o Represents a health care drug, intervention, device, technology or health care … Product makers (i.e., drug and device manufacturers): representatives were asked to participate in

  3. Renal-Function Executive (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/renal-function_executive.pdf
    August 01, 2014 - Non-ACS conditions can include noncoronary causes (e.g., sepsis, congestive heart failure, myocarditis, drug … Food and Drug Administration approved the measurement of troponin T in dialysis patients for the express … Food and Drug Administration approved the measurement of troponin T in dialysis patients for the express … Regarding CKD patients without suspected ACS, our findings support the current Food and Drug Administration

  4. Translation of a C. difficile Treatment Clinical Pathway Into Machine-Readable Clinical Decision Support Artifacts Prototyped for Electronic Health Record Implementation (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-report-translation-c-diff-treatment-clinical-pathway.pdf
    November 01, 2019 - diagnosing C. diff. 18) Does the recommendation specify patient characteristics (such as coincident drug … trigger the thought. 18) Does the recommendation specify patient characteristics (such as coincident drug … Recommendations 18) Does the recommendation specify patient characteristics (such as coincident drug

  5. Gout Dx protocol_140715-draft (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/gout_research-protocol-2014.pdf
    January 01, 2014 - Some 32 percent of the costs were attributed to gouty arthritis attacks, and drug expenditures accounted

  6. Automated-Entry Patient Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/patient-generated-health-data-protocol-chronic-conditions.pdf
    March 17, 2020 - Food and Drug Administration [FDA]), and relevant professional societies (e.g. the American Health Information

  7. Evidence-based Practice Center Technical Brief Protocol (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/pain-chronic_research-protocol.pdf
    July 28, 2010 - Evidence-based Practice Center Technical Brief Protocol Source: www.effectivehealthcare.ahrq.gov Published Online: July 28, 2010 1 Evidence-based Practice Center Technical Brief Protocol Project Title: Technical Brief - Multidisciplinary Pain Programs for Chronic Non-Cancer Pain I. Background an…

  8. Comparative Effectiveness of Treatments for Cryptorchidism | Effective Health Care (EHC) Program

    effectivehealthcare-admin.ahrq.gov/products/undescended-testicle/research-protocol
    September 02, 2011 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

  9. Technical Brief: Multidisciplinary Pain Programs for Chronic Non-Cancer Pain | Effective Health Care (EHC) Program

    effectivehealthcare-admin.ahrq.gov/products/pain-chronic/research-protocol
    July 28, 2010 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

  10. Comparative Effectiveness of Treatment for Open-Angle Glaucoma | Effective Health Care (EHC) Program

    effectivehealthcare-admin.ahrq.gov/products/glaucoma-treatment/research-protocol
    November 16, 2010 - A detailed description of Food and Drug Administration (FDA) approval status, indications, and warnings

  11. Comparative Effectiveness of Screening for Glaucoma | Effective Health Care (EHC) Program

    effectivehealthcare-admin.ahrq.gov/products/glaucoma-screening/research-protocol
    November 16, 2010 - A detailed description of Food and Drug Administration (FDA) approval status, indications, and warnings

  12. Diagnosis of Gout | Effective Health Care (EHC) Program

    effectivehealthcare-admin.ahrq.gov/products/gout/research-protocol-2014
    July 17, 2014 - Some 32 percent of the costs were attributed to gouty arthritis attacks, and drug expenditures accounted

  13. Evidence-based Practice Center Systematic Review Protocol (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hyperactivity-disorder-protocol.pdf
    November 10, 2024 - Food and Drug Administration VII. … Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services.

  14. Diagnosis of Attention-Deficit/Hyperactivity Disorder in Adults: A Systematic Review (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hyperactivity-disorder-protocol-amendment.pdf
    January 08, 2025 - Food and Drug Administration VII. … Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services.

  15. Cancer-Ovarian-Contraceptives Executive (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_executive.pdf
    June 01, 2013 - We invited drug manufacturers to submit additional information through a scientific information packets … Manual searching and contacts with drug manufacturers via the scientific information packet requests

  16. The Performance of Fusion Procedures for Degenerative Disease of teh Lumbar Spine (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/lumbar-fusion-protocol.pdf
    June 20, 2024 - interbody fusion; DLS = degenerative lumbar spondylolisthesis; EQ-5D = EuroQol 5D scale; FDA = Food and Drug … lumbar spondylolisthesis; EQ-5D = EuroQol 5D scale; ESI = epidural steroid injection; FDA = Food and Drug

  17. Diagnosis of Attention-Deficit/Hyperactivity Disorder in Adults: A Systematic Review | Effective Health Care (EHC) Program

    effectivehealthcare-admin.ahrq.gov/products/hyperactivity-disorder/protocol
    January 08, 2025 - Food and Drug Administration VII. … Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services.

  18. Masks for Prevention of COVID-19 in Community and Healthcare Settings (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/rapid-review-masks-prevention-covid-version-1.pdf
    December 01, 2021 - Infect Disord Drug Targets. 2014;14(2):110-6. doi: 10.2174/1871526514666141021112855. … Infect Disord Drug Targets. 2014;14(2):110-6. doi: 10.2174/1871526514666141021112855.

  19. Disposition of Comments for CER 147 Menopausal Symptoms: Comparative Effectiveness of Therapies (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/menopause_disposition-comments.pdf
    March 05, 2015 - consider when making clinical recommendations about relative efficacy of hormonal vs. nonhormonal drug

  20. Medical-Evidence-Communication Research-Protocol (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/medical-evidence-communication_research-protocol.pdf
    July 31, 2012 - o Negative (loss) frame: “With drug X, you have a 5% chance of dying” vs. … “With drug X, you have a 95% chance of surviving.”
SHARE:
Facebook Twitter Print Facebook Share

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site:

View results from all sites